Distribution of participants by change in SARS-CoV-2 seropositivity status by round and area.</p
Distribution of seroprevalence, seroconversion, and increase in antibody titer of HCW from baseline ...
Distribution of markers in the total cohort and in HER2-positive and HER2-negative patients.</p
Distribution of study participants by across TB screening countries (MRS analysis population).</p
Distribution of SARS-CoV-2 seropositive of participants by round, vaccination status and site.</p
Distribution of SARS-CoV-2 seropositive participants by site, round, and sex.</p
Distribution of SARS-CoV-2 seropositive of participants by site, round and age group (<18 years and ...
Percent distribution of the enrolled participants by their experienced Post COVID 19 symptoms (n=417...
Percent distribution of the enrolled participants by COVID-19 disease source of knowledge (n=417).</...
The distribution of SARS-CoV-2 S protein mutations detected in samples collected during four differe...
Percent distribution of study participants according to their most needed information about COVID-19...
<p>Distribution of individual and household-level characteristics by serologic and radiologic result...
Gender and age distribution of the participants and their SARS-CoV-2 PCR and anti-NC-Ab results at 2...
Distribution of COVID-19 confirmed cases and deaths according to symptoms on admission.</p
Seroprevalence of SARS -CoV-2 (seroprevalence = n/N*100, N = Total participants and n = SARS-COV-2 p...
<p>Distribution of MERS-CoV infections in humans by region and country, along with the date of first...
Distribution of seroprevalence, seroconversion, and increase in antibody titer of HCW from baseline ...
Distribution of markers in the total cohort and in HER2-positive and HER2-negative patients.</p
Distribution of study participants by across TB screening countries (MRS analysis population).</p
Distribution of SARS-CoV-2 seropositive of participants by round, vaccination status and site.</p
Distribution of SARS-CoV-2 seropositive participants by site, round, and sex.</p
Distribution of SARS-CoV-2 seropositive of participants by site, round and age group (<18 years and ...
Percent distribution of the enrolled participants by their experienced Post COVID 19 symptoms (n=417...
Percent distribution of the enrolled participants by COVID-19 disease source of knowledge (n=417).</...
The distribution of SARS-CoV-2 S protein mutations detected in samples collected during four differe...
Percent distribution of study participants according to their most needed information about COVID-19...
<p>Distribution of individual and household-level characteristics by serologic and radiologic result...
Gender and age distribution of the participants and their SARS-CoV-2 PCR and anti-NC-Ab results at 2...
Distribution of COVID-19 confirmed cases and deaths according to symptoms on admission.</p
Seroprevalence of SARS -CoV-2 (seroprevalence = n/N*100, N = Total participants and n = SARS-COV-2 p...
<p>Distribution of MERS-CoV infections in humans by region and country, along with the date of first...
Distribution of seroprevalence, seroconversion, and increase in antibody titer of HCW from baseline ...
Distribution of markers in the total cohort and in HER2-positive and HER2-negative patients.</p
Distribution of study participants by across TB screening countries (MRS analysis population).</p